ICDcodes.org
FY2027

E09.37X3Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral

Billable

Is E09.37X3 billable?

Yes — E09.37X3 is billable for FY2027. E09.37X3 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E09.37X3 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E09.37X3 at a glance

CodeE09.37X3
DescriptionDrug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "3"bilateral

What does the 7th character "3" mean in E09.37X3?

In E09.37X3, the 7th character 3 means bilateral. The 7th character is required for E09.37X3 to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

Which MS-DRGs does E09.37X3 group to?

E09.37X3 sits in MDC Pre and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 008Simultaneous Pancreas, Islet Cell and Kidney Transplantsurgical

How is E09.37X3 listed in the Alphabetic Index?

The Alphabetic Index lists these routes under E09.37, the nearest indexed parent of E09.37X3. Use them to find the family, then select the specific code.

  • Diabetes, diabeticdue to drug or chemicalwithretinopathyresolved following treatment (mellitus) (sugar)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E09.37X3 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E09

The conditions below can never be reported together with E09.37X3 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes mellitus due to underlying condition (E08.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)

Code first — inherited from E09

The underlying condition below must be sequenced before E09.37X3. E09.37X3 describes a manifestation and cannot be the principal or first-listed diagnosis.

  • poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Use additional code — inherited from E09

Report an additional code alongside E09.37X3 to fully describe the condition. E09.37X3 is sequenced first.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

How long has E09.37X3 existed?

E09.37X3 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.